Avidity Biosciences RNA Revolution 2021

Avidity Biosciences presents its RNA therapeutics platform and development strategy, showcasing the company's AOC-based approach to discovering and developing RNA therapeutic candidates. The presentation outlines preclinical research efforts, clinical trial timelines, and the company's vision to revolutionize RNA therapeutics delivery for diseases like myotonic dystrophy.